Suzhou Transcenta Therapeutics Co., Ltd.

This study tests a new drug called TST003 in about 111 people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check side effects, and see if the drug can shrink tumors. Participants receive the drug through a ve…

This study tests a new drug called TST001, an antibody that targets a protein (CLDN18.2) found on some cancer cells. It is for people with advanced solid tumors, including stomach, gastroesophageal junction, and pancreatic cancers. The trial aims to find safe doses and see how we…